Yan Sun
Capital Medical University
31 Papers
4 Citations
Yan Sun is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Percutaneous coronary intervention. The author has an hindex of 6, co-authored 17 publications.
Chat about Author
Papers
Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome
Xiaoteng Ma,Lisha Dong,Qiaoyu Shao,Yujing Cheng,Sai Lv,Yan Sun,Hua Shen,Zhijian Wang,Yujie Zhou,Xiaoli Liu +9 more
TL;DR: TheTyG index was significantly and positively associated with adverse CV outcomes, suggesting that the TyG index may be a valuable predictor of adverseCV outcomes after PCI in patients with T2DM and ACS.
Platelet-Derived Exosomes Affect the Proliferation and Migration of Human Umbilical Vein Endothelial Cells Via miR-126
TL;DR: Activated PLT-EXOs promoted the proliferation and migration of HUVECs, and the overexpression of miR-126 and angiogenic factors, thereby elucidating potential new therapeutic targets for intraplaque angiogenesis.
51
Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention
Xiaoteng Ma,Yan Sun,Yujing Cheng,Hua Shen,Fei Gao,Jing Qi,Lixia Yang,Zhijian Wang,Dongmei Shi,Yuyang Liu,Xiaoli Liu,Yujie Zhou +11 more
TL;DR: A higher AI P value on admission was independently and strongly associated with adverse cardiovascular events in T2DM patients with ACS undergoing PCI.
Omentin-1 Modulates Macrophage Function via Integrin Receptors αvβ3 and αvβ5 and Reverses Plaque Vulnerability in Animal Models of Atherosclerosis
Xuze Lin,Yan Sun,Shi-Wei Yang,Mengyue Yu,Liu Pan,Jie Yang,Jiaqi Yang,Qiaoyu Shao,Jinxing Liu,Yan Liu,Yujie Zhou,Zhijian Wang +11 more
TL;DR: In this article, the effect of omentin-1 on the plaque phenotype was investigated by implanting a minipump in ApoE−/− and Ldlr−/ − mice and further, study its underlying mechanisms.
24
Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
Kexin Wang,Rui Wang,Jia-xing Yang,Xiaoli Liu,Hua Shen,Yan Sun,Yujie Zhou,Zhe Fang,Hai Long Ge +8 more
TL;DR: The use of statins, fibrates, APOC3 inhibitors, PCSK9 inhibitors, and omega-3 fatty acids to reduce RC levels in the plasma may provide long-term benefits, and more studies on appropriate treatments of elevated RC are urgently needed.